Cannabinoids

Congressional Committee Calls For Cannabis And Kratom Research

They also slammed the restrictions on research placed on Schedule I narcotics

A powerful congressional committee is expressing concerns about barriers to marijuana research created by the drug’s Schedule I status. The panel also called for studies on CBD and kratom as potential alternatives to opioid-based painkillers in its supplemental report on a spending bill released on Wednesday.

Some of the language around cannabis research has previously appeared in House and Senate Appropriations Committee reports on the relevant legislation, which is meant to designate funds for the Departments of Labor, Health and Human Services and Education.

The House committee said in the new report that it is “concerned that restrictions associated with Schedule I of the Controlled Substance Act effectively limit the amount and type of research that can be conducted on certain Schedule I drugs, especially marijuana or its component chemicals and new synthetic drugs and analogs.”


To Read The Rest Of This Article On Marijuana Moment, Click Here

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

  • Exotic Blvd

CHAMPS Smoke Shop Report, or ‘CSS’, online source for the updates and innovations on the smoke shop scene. News and information are geared strictly to accessories retail channels, with distribution limited to retailers that Smoke Shop products and wholesalers.

Newsletter

Stay informed with the most up-to-date industry news to help you grow your business: subscribe to our newsletter below!


To Top